Non-small Cell Lung Cancer
6 drugs1,479 FAERS reportsMedDRA PT
GET
/api/v1/reaction/non-small-cell-lung-cancerReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Non-small Cell Lung Cancer (6)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Sotorasib49916%
- 2Ceritinib1295.4%
- 3Capmatinib954.1%
- 4Amivantamab832.9%
- 5Crizotinib2812.2%
- 6Brigatinib392—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Lung Neoplasm Malignant4 shared · 0.40
- Metastases To Central Nervous System2 shared · 0.10
- Neoplasm Progression3 shared · 0.08
- Pleural Effusion2 shared · 0.06
- Hepatic Function Abnormal2 shared · 0.05
- Oedema Peripheral3 shared · 0.04
- Aspartate Aminotransferase Increased2 shared · 0.03
- Alanine Aminotransferase Increased2 shared · 0.03
- Malignant Neoplasm Progression4 shared · 0.03
- Peripheral Swelling2 shared · 0.02
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.